V009-6113 Screening compound: N-(butan-2-yl)-N-{2-[4-(2-methylphenyl)-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl]-2-oxoethyl}-2,2-diphenylacetamide

V009-6113 Screening compound: N-(butan-2-yl)-N-{2-[4-(2-methylphenyl)-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl]-2-oxoethyl}-2,2-diphenylacetamide
V009-6113 Screening compound: N-(butan-2-yl)-N-{2-[4-(2-methylphenyl)-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl]-2-oxoethyl}-2,2-diphenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-6113
N-(butan-2-yl)-N-{2-[4-(2-methylphenyl)-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl]-2-oxoethyl}-2,2-diphenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-6113

Molecular Formula

C34H36N2O2S (C34 H36 N2 O2 S)

Compound Name

N-(butan-2-yl)-N-{2-[4-(2-methylphenyl)-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl]-2-oxoethyl}-2,2-diphenylacetamide

IUPAC name

N-(butan-2-yl)-N-{2-[4-(2-methylphenyl)-4H5H6H7H-thieno[32-c]pyridin-5-yl]-2-oxoethyl}-22-diphenylacetamide

SMILES

CCC(C)N(CC(N(CCc1c2ccs1)C2c1c(C)cccc1)=O)C(C(c1ccccc1)c1ccccc1)=O

InChI

InChI=1S/C34H36N2O2S/c1-4-25(3)36(34(38)32(26-14-7-5-8-15-26)27-16-9-6-10-17-27)23-31(37)35-21-19-30-29(20-22-39-30)33(35)28-18-12-11-13-24(28)2/h5-18,20,22,25,32-33H,4,19,21,23H2,1-3H3

InChI Key

NLIKGVAKCYSGDB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19764613

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

536.74

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

7.526

Distribution Coefficient, logD

7.526

Water Solubility, LogSw

-5.72

Polar Surface Area

31.892

Acid Dissociation Constant (pKa)

15.87

Base Dissociation Constant (pKb)

-1.72

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

29.40

V009-6113 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V009-6113 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-6113?
Check Price and Availability of V009-6113, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-6113 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-6113
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-6113
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-6113 available by request